Friday, January 15, 2021
Wednesday, January 13, 2021
AbCellera Biologics (ABCL) began trading on the Nasdaq on Fri 11 Dec 20
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 174
- Founded in 2012
- Headquartered in Vancouver, Canada
- http://www.abcellera.com
AbCellera Biologics CEO Carl Hansen on CNBC on Wed 1/13/21
Labels:
1-month performance,
2020 IPOs,
ABCL,
biotech IPOs,
Canadian IPOs,
NASDAQ
Tuesday, January 12, 2021
Subscribe to:
Posts (Atom)